Sunnybrook Health Science Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2019

  1. Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion

    PLoS ONE, Vol. 14, Núm. 9

2008

  1. Metronomic antiangiogenic chemotherapy: Questions and answers

    Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy (Springer Berlin Heidelberg), pp. 593-607

2007

  1. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing

    Cancer and Metastasis Reviews, Vol. 26, Núm. 3-4, pp. 737-747

2006

  1. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy

    Cancer Research, Vol. 66, Núm. 7, pp. 3386-3391

2005

  1. Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy

    Breast, Vol. 14, Núm. 6, pp. 466-479

  2. Cellular and molecular surrogate markers to monitor targeted and non-targeted antiangiogenic drug activity and determine optimal biologic dose

    Current Cancer Drug Targets, Vol. 5, Núm. 7, pp. 551-559